The combination of NVP-BKM120 with trastuzumab or RAD001 synergistically inhibits the growth of breast cancer stem cells in vivo
2016 · Oncology Reports · 27 citations
https://doi.org/10.3892/or.2016.4799
Tianjin Medical University Cancer Institute and Hospital(CN)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
11
Papers
204
Citations
7
h-index
7
i10-index
Jingchao Bai is an academic researcher from Tianjin Medical University Cancer Institute and Hospital. The author has contributed to research in topics: Cancer Genomics and Diagnostics & Genomic variations and chromosomal abnormalities & Cancer Cells and Metastasis. The author has an h-index of 7, co-authored 10 publications.
ORCID: 0000-0001-8228-9730https://doi.org/10.3892/or.2016.4799
https://doi.org/10.4161/cc.28201
Click to start Chat